Primary study · included by 1 review

First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients.

Zacherl 2021 · Zacherl Mathias Johannes, Gildehaus Franz Josef, Mittlmeier Lena, et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.

Non-Cochrane · intervention · 2026 · cited as Zacherl 2021 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.